D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
APGE holding history
Apogee Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APGE overviewAll 13F holders of APGEFull Q2 2026 holdings
- Shares (Q2 2026)
- 246,086
- Value
- $32.7M
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 246,086 | $32.7M | <0.1% | +187,251+318.3% | Added | Holders |
| Q1 2026 | 58,835 | $4.95M | <0.1% | −4,415−7.0% | Reduced | Holders |
| Q4 2025 | 63,250 | $4.77M | <0.1% | −37,320−37.1% | Reduced | Holders |
| Q3 2025 | 100,570 | $4.00M | <0.1% | −93,958−48.3% | Reduced | Holders |
| Q2 2025 | 194,528 | $8.45M | <0.1% | +185,752+2,116.6% | Added | Holders |
| Q1 2025 | 8,776 | $327.9K | <0.1% | −1,037−10.6% | Reduced | Holders |
| Q4 2024 | 9,813 | $444.5K | <0.1% | −39,849−80.2% | Reduced | Holders |
| Q3 2024 | 49,662 | $2.92M | <0.1% | −2,364−4.5% | Reduced | Holders |
| Q2 2024 | 52,026 | $2.05M | <0.1% | +52,026 | New | Holders |